Open access
Jul 2026
Multi-omic discovery of SCG5 as a shared driver and prognostic biomarker in head-neck and non-small cell lung cancers
Downregulation of SCG5 suppresses the growth of HNSC and NSCLC cells, potentially through modulating the PI3K/AKT signaling pathway, thereby presenting a potential therapeutic target for both malignancies.
Feng Zhao, Hai-Ning Wang, Tao Qin et al.
· Discover Oncology · 0 citations